International Airport Limited (MIAL), a joint venture between Airports
Authority of India (AAI) and GVK, has become the first Indian airport and third
in Asia to achieve the International Air Transport Association (IATA) Center of
Excellence for Independent Validators (CEIV) Pharma certification.
achieved this quality milestone for pharma logistics following successful
completion of training courses, on-site assessment, and complex validation
processes. Acknowledging the importance of this initiative, MIAL has initiated
the certification process in a community approach manner together with its air
cargo supply chain partners.
CEIV Pharma certification is introduced to prevent temperature excursions of
pharma products during air transport with the key objective of patient safety
and reduction of losses attributed to logistical issues. It aims to improve the
handling of pharmaceutical cargo by complying with existing national and
international regulations. The authorisation ensures seamless handling,
adequately equipped facilities, safety & security, standardisation and
transparency in the pharma supply chain across the air transport.
GVK is a
majority stakeholder in MIAL with 74 percent stake while AAI holds the
remaining 26 percent.